Jan 2025· Bioinform.· Vol 42· 1 citation· 52 references
Computer ScienceMedicine
Abstract
Abstract Motivation Retrosynthesis plays a crucial role in organic synthesis and drug discovery, focusing on identifying a set of reactants capable of synthesizing a target product molecule. Although the existing approaches have shown promising results, they do not fully exploit 3D conformer information and molecular spatial structure, which can hinder stereochemically consistent and chemically plausible predictions. Results To tackle this problem, we propose ConfRetro, a Transformer-based template-free method that integrates molecular conformer information and spatial structure. We devise an Atom-align Fusion module to combine 3D positional information at the model input stage, ensuring alignment between atom tokens and corresponding 3D representations. Furthermore, we design a Distance-weighted Attention mechanism to guide self-attention, constraining the receptive field of model and emphasizing chemically relevant atom pairs in 3D space. Experiments conducted on the USPTO-50K and USPTO-FULL datasets demonstrate that ConfRetro significantly outperforms existing template-free approaches, achieving a new state-of-the-art performance. Case studies further highlight its capability to predict accurate and chemically plausible reactants, even for target molecules with intricate structures. Moreover, when plugged into a standard retrosynthetic search, ConfRetro recovers feasible synthetic routes for multiple representative drug molecules (e.g. Camptothecin). Availability and implementation ConfRetro is available at https://github.com/Jesse-zjx/ConfRetro. Archival snapshot is available at https://doi.org/10.5281/zenodo.20785018.
These syntheses confirmed viable, previously unreported substrate combinations for established, classic reaction paradigms─specifically, the Suzuki-Miyaura coupling, the Bucherer reaction, and the Friedel-Crafts acylation, thereby suggesting that RetroMPA can operate beyond mere data fitting.
Mianzhi Liu, Fan Xiao, Zhi-Qiang Yu et al.· Journal of Chemical Informat...· 0 citations
LinkerBridge is proposed, an equivariant framework that unifies biochemical semantics with physical constraints through two innovations: a Contextual Interaction-Aware Representation module that internalizes pre-existing bio-chemical semantics and a Differentiable Physical Guidance mechanism derived from Van der Waals...
Meng-Wei Sun, Chengwei Ai, Xiao-Yi Liu et al.· Proceedings of the Thirty-Fi...· 0 citations
Current structure-based drug design generative models often struggle to faithfully recapitulate genuine ligand-protein binding interactions. Instead, under the coupling of implicit learning architectures and biased training data, they tend to learn spurious statistical correlations. To address this, we propose EIP-Diff...
Huabin Du, Mingyang Wang, M. Luo et al.· Journal of the American Chem...· 0 citations
LiFT, a language-informed cross-modal framework built on Flow Matching for trend-guided 3D molecular generation across both de novo design and scaffold hopping, and suggests that language-derived chemical priors provide effective trend-level guidance for 3D molecular generation.
Tian-Yu Gao, Zhi-Kai Su, Jia-Shu Li et al.· 0 citations
Vilya-1 is introduced, a deep learning model that addresses two central challenges in macrocycle design: sampling biologically relevant conformations across arbitrary chemistries and predicting key developability properties such as membrane permeability.
Vilya Research Pascal Sturmfels, M. Salem, Naozumi Hiranuma et al.· arXiv.org· 1 citation
Biomolecular binder design for peptides and antibodies requires generating diverse candidates that satisfy stringent three-dimensional geometric constraints while enabling affinity-oriented exploration under strong structural priors. In current generative models, the effective search space for structurally feasible bin...
Zhihua Tian, Jia-Le Zhou, Ru-Bo Wang et al.· Proceedings of the 32nd ACM...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.